BCL2L11 and neoplasm: The tumor compartment of primary samples had significantly higher expression of immune cell markers CD45, CD8, ARG1, GZMB, BIM, BCL2, showing brain metastases have very few immune cells infiltrating in the tumor epithelium (Fig. 5C).